These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3780234)

  • 1. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women.
    Lindsay R; Tohme J; Kanders B
    Contraception; 1986 Oct; 34(4):333-40. PubMed ID: 3780234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-sparing properties of oral contraceptives.
    DeCherney A
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone loss, contraception and lactation.
    Mehta S
    Acta Obstet Gynecol Scand; 1993 Apr; 72(3):148-56. PubMed ID: 8385847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and bone mineral density: A population-based study.
    Pasco JA; Kotowicz MA; Henry MJ; Panahi S; Seeman E; Nicholson GC
    Am J Obstet Gynecol; 2000 Feb; 182(2):265-9. PubMed ID: 10694322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
    Murphy S; Khaw KT; Compston JE
    Eur J Clin Invest; 1993 Feb; 23(2):108-11. PubMed ID: 8462619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral contraceptive use does not affect trabecular bone density.
    Lloyd T; Buchanan JR; Ursino GR; Myers C; Woodward G; Halbert DR
    Am J Obstet Gynecol; 1989 Feb; 160(2):402-4. PubMed ID: 2916626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactation history and bone mineral density among perimenopausal women.
    Feldblum PJ; Zhang J; Rich LE; Fortney JA; Talmage RV
    Epidemiology; 1992 Nov; 3(6):527-31. PubMed ID: 1420520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months.
    Hergenroeder AC; Smith EO; Shypailo R; Jones LA; Klish WJ; Ellis K
    Am J Obstet Gynecol; 1997 May; 176(5):1017-25. PubMed ID: 9166162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ; Evans MC; Ames RW; Clearwater JM; Cundy T; Reid IR
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):615-8. PubMed ID: 10197077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy.
    Lee AJ; Lowe GD; Smith WC; Tunstall-Pedoe H
    Br J Haematol; 1993 Apr; 83(4):616-21. PubMed ID: 8518178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
    Caird LE; Reid-Thomas V; Hannan WJ; Gow S; Glasier AF
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):739-45. PubMed ID: 7889609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of endometrial cancer in relation to the use of oral contraceptives.
    Weiss NS; Sayvetz TA
    N Engl J Med; 1980 Mar; 302(10):551-4. PubMed ID: 7351890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives for the prevention of osteoporosis.
    Corson SL
    J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast cancer: review of the epidemiologic literature.
    Thomas DB
    Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.